๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nanjing
Clinical trial register · China

Clinical Trials in Nanjing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University201 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School89 Nanjing First Hospital, Nanjing Medical University68 The Second Hospital of Nanjing Medical University32 Nanjing Medical University30
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Nanjing

1193 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
NCT06676527Neoplasms, Kidney Neoplasms, Urologic Neoplasms, Urogenital Neoplasms
Jinling Hospital, China
Observational
39
Nanjing
2024-09-01
Not yet open
Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment
NCT06571214Infertility
Nanjing University
Phase 4
300
Nanjing
2024-09-01
By invitation
Clinical Study on the Application of Lactulose Combined with Linaclotide in Bowel Preparation for Colonoscopy
NCT06748638Lactulose, Bowel Preparation
Haifeng Lan
Phase 4
444
Nanjing
2024-09-01
Not yet open
A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients
NCT06469879Small Cell Lung Cancer Limited Stage
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
358
Hefei, Lanzhou, Nanjing, Tangshan, Harbin, Anyang, Xiangyang, Changsha
2024-09
Not yet open
Modified Water Vapor Thermal Therapy in Management of Patients With Large-volume Benign Prostatic Hyperplasia
NCT06596590Benign Prostatic Hyperplasia
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
76
Nanjing
2024-09
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
AstraZeneca
Phase 2
120
Beijing, Chengdu, Guangzhou, Hangzhou, Nanchang, Nanjing, Wuhan
2024-08-28
Active, closed
MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma
NCT06640153Gastric Cancer, Gastroesophageal Junction Cancer
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-08-21
Not yet open
To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer
NCT06561646Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
60
Nanjing
2024-08-21
Recruiting
Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
NCT06891157Chidamide, R-CHOP Chemotherapy, DLBCL - Diffuse Large B Cell Lymphoma, Double-expressor Lymphoma (DEL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
148
Nanjing
2024-08-20
Recruiting
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
NCT07122414Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Active, closed
Acupuncture for Enhancing Immunotherapy in Advanced NSCLC๏ผša Pilot Study
NCT06461338Non-small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma
Guangzhou University of Traditional Chinese Medicine
Not applicable
60
Guangzhou, Nanjing
2024-08-15
Not yet open
The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus
NCT06546436Autoimmune Type 1 Diabetes Mellitus(T1DM)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase EARLY_PHASE1
12
Nanjing
2024-08-15
Recruiting
Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)
NCT06656624Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
190
Nanjing
2024-08-13
Recruiting
Scoring Balloon and High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis
NCT06503692Arteriovenous Graft Stenosis
DK Medical Technology (Suzhou) Co., Ltd.
Not applicable
140
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Shanghai
2024-08-13
Recruiting
Clinical Research Protocol of Ferumoxytol for Magnetic Resonance Enhancement Imaging in Patients With Atherosclerosis.
NCT06551805Atherosclerosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
100
Nanjing
2024-08-12
Active, closed
Posterior Minimally Invasive Surgery for Treating Paralytic Scoliosis With Pelvic Obliquity in Children Following Spinal Cord Injury
NCT07594574Paralytic Scoliosis, Pelvic Obliquity, Spinal Cord Injury, Neuromuscular Scoliosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
39
Nanjing
2024-08-10
Recruiting
Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis
NCT06543992Leptomeningeal Metastasis of Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
22
Nanjing
2024-08-08
Active, closed
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
NCT06332014Osteoporosis
Amgen
Phase 4
102
Beijing, Chongqing, Guangzhou, Harbin, Huaian, Nanjing, Suzhou, Xuzhou
2024-08-06
Recruiting
A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer
NCT06555471Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2024-08-06
Recruiting
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
NCT06371157Hepatocellular Carcinoma
Akeso
Phase 3
469
Zhengzhou, Changsha, Nanjing, Hangzhou
2024-08-02
Recruiting
Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC
NCT06992232Prostate Cancer Metastatic Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
144
Nanjing
2024-08-01
By invitation
Immunochemotherapy ยฑ Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy
NCT07016737Esophageal Squamous Cell Carcinoma (ESCC)
Ye jinjun
Phase 3
79
Nanjing
2024-08-01
Recruiting
Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes
NCT06273631Type 1 Diabetes, Diet Intervention, Glucose Control
Yang Tao
Not applicable
80
Nanjing
2024-08-01
Recruiting
Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome
NCT07691125Short Bowel Syndrome (SBS) in Adults
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 4
100
Xiamen, Nanjing
2024-07-31
Recruiting
CPVI With Modified Linear Ablation Versus CPVI in Patients With Long-standing Persistent Atrial Fibrillation (SINUS)
NCT06516822Long-standing Persistent Atrial Fibrillation, Ablation
The First Affiliated Hospital with Nanjing Medical University
Not applicable
320
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Dalian, Jinan, Xiโ€™an
2024-07-31
Recruiting
Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules
NCT06423235Thyroid Nodule
Xintian Pharmaceutical
Phase 4
234
Chongqing, Xiamen, Guangzhou, Shenzhen, Shunde, Wuhan, Nanjing, Xuzhou
2024-07-30
Recruiting
Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases
NCT06619808Metabolic Dysfunction-associated Steatotic Liver Disease, Hepatic Steatosis, Non-alcoholic Fatty Liver Diseases
Jinling Hospital, China
Not applicable
150
Nanjing
2024-07-29
Recruiting
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
NCT06083207Multiple Myeloma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Beijing, Nanning, Wuhan, Nanjing, Suzhou, Xuzhou, Nanchang, Shanghai
2024-07-29
Recruiting
PulseSelectโ„ข PFA Global Registry
NCT06393920Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
1,950
Beijing, Fuzhou, Harbin, Kunming, Nanjing, Shanghai, Shenzhen, รœrรผmqi
2024-07-23
Recruiting
IVI-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus
NCT06380868Diabetes
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,332
Nanjing
2024-07-17
Recruiting
Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
NCT06791148Gastric Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
45
Nanjing
2024-07-10
Recruiting
A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
NCT07250542Prostate Cancer
baotai Liang
Phase 2
30
Nanjing
2024-07-05
Not yet open
LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
NCT06472479Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University
Not applicable
66
Hefei, Zhengzhou, Nanjing, Beijing
2024-07-01
Recruiting
Recurrent Liver Cancer: Reconceptualization and Reevaluation
NCT06430983Recurrent Liver Cancer, Primary Liver Cancer
Nanjing Medical University
Observational
300
Nanjing
2024-07-01
Recruiting
PyroEVs/PLIN3 Mediate Lipid Droplet-Mitochondrial Coupling in Sepsis Endothelial Injury
NCT07727265Sepsis
Zhongda Hospital
Observational
180
Nanjing
2024-07-01
Recruiting
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
NCT06390306Chronic Myeloid Leukemia
Peking University People's Hospital
Observational
30
Beijing, Chengdu, Guangdong, Kunming, Nanjing, Nanning, Nanyang, Ningbo
2024-07-01
Recruiting
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
NCT07777744Ventricular Tachycardia (VT), Premature Ventricular Complexes
University Hospital, Basel, Switzerland
Observational
15,000
Nanjing
2024-07-01
Active, closed
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682Diabetic Kidney Disease, Type 1 Diabetes
The First Affiliated Hospital with Nanjing Medical University
Phase 4
54
Nanjing
2024-07-01
Active, closed
SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer
NCT06465563Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
93
Nanjing, Hangzhou
2024-07-01
Not yet open
Catheter Ablation of Haemodynamically Not-tolerated Electrical Storm in Structural Heart Disease
NCT06455020Ventricular Tachycardia
Beijing Anzhen Hospital
Not applicable
96
Beijing, Changsha, Kunming, Nanjing
2024-07-01
Recruiting
Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)
NCT06195267Aortic Dissection, Systemic Inflammatory Response Syndrome, Cardiovascular Diseases (CVD)
Nanjing Medical University
Not applicable
500
Beijing, Nanjing
2024-07-01
Recruiting
DRug-coAted Balloon Compared With cuttinG balloON in Treatment of Arteriovenous Fistula Stenosis
NCT06527963Arteriovenous Fistula, Angioplasty, Balloon, Hemodialysis Access Failure
RenJi Hospital
Observational
180
Zhengzhou, Nanjing, Shanghai
2024-07-01
Recruiting
Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer
NCT06431620Recombinant Human Thyroid Stimulating Hormone
Nanjing First Hospital, Nanjing Medical University
Not applicable
15
Nanjing
2024-06-30
By invitation
Effects of Repetitive Transcrannial Magnetic Stimulation on Non-Suicidal Self-Injury
NCT06540300NSSI
Nanjing Medical University
Not applicable
60
Nanjing
2024-06-30
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
NCT06324357Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma
Boehringer Ingelheim
Phase 1/2
768
Changchun, Hangzhou, Harbin, Nanjing, Shanghai, Tianjin, Zhengzhou
2024-06-28
Recruiting
Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations
NCT06479343Intracranial Arteriovenous Malformations
Ton-Bridge Medical Tech. Co., Ltd
Not applicable
170
Guangzhou, Zhengzhou, Nanjing, Changchun, Shenyang, Jinan, Beijing, Chengdu
2024-06-27
Recruiting
Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation
NCT06536400Solid Tumors
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
316
Beijing, Fuzhou, Guangzhou, Nanning, Zhengzhou, Changsha, Nanjing, Shanghai
2024-06-25
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
NCT06455449Polymyositis, Dermatomyositis
AstraZeneca
Phase 3
240
Beijing, Chongqing, Dongguan, Guangzhou, Hangzhou, Hengyang, Jining, Nanjing
2024-06-20
Recruiting
the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children
NCT05911893Malnutrition, Child, Malnourishment, Nutritional Deficiency, Undernutrition
Children's Hospital of Chongqing Medical University
Not applicable
200
Hefei, Beijing, Jilin City, Chongqing, Guangzhou, Guiyang, Changsha, Nanjing
2024-06-17
Recruiting
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
NCT06378242High-risk Non-muscle Invasive Bladder Cancer
RemeGen Co., Ltd.
Phase 1/2
24
Guangzhou, Wuhan, Changsha, Nanjing, Chengdu, Tianjin
2024-06-14
Recruiting
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06461910Gastric Cancer, Esophagogastric Junction Adenocarcinoma
Zekuan Xu
Phase 2
30
Nanjing
2024-06-14
Recruiting
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
NCT06461377Type 2 Diabetes, Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University
Phase 4
50
Nanjing
2024-06-13
Active, closed
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
NCT06472076Lung Cancer, Non-Small Cell
GlaxoSmithKline
Phase 3
88
Chengdu, Hangzhou, Hefei, Nanjing, Shanghai
2024-06-10
Recruiting
Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability
NCT06430554Respiratory Distress Syndrome, Positive-Pressure Respiration, Mechanical Ventilation
Zhongda Hospital
Observational
40
Nanjing
2024-06-08
Recruiting
A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Pre-COPD Outcomes in Chinese Population
NCT06724848COPD
AstraZeneca
Observational
850
Beijing, Changsha, Chengdu, Guangzhou, Hefei, Nanjing, Nanning, Shanghai
2024-06-05
Recruiting
A Trail of Sperstentยฎ Used for Residual Lesions of Femoropopliteal Arteries
NCT06539689Peripheral Arterial Disease, Stenosis, Dissection
FrontAce Scientific Co., Ltd
Not applicable
240
Beijing, Chongqing, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Nantong, Shanghai
2024-06-04
Active, closed
Exoskeleton Training on Balance Control and Turning in Ambulation in Individuals With Incomplete Spinal Cord Injury
NCT06971510Spinal Cord Injuries
Hong Kong Metropolitan University
Not applicable
32
Changzhou, Nanjing, Hong Kong
2024-06-01
Not yet open
Washed Microbiota Transplantation for Allergic Rhinitis
NCT06372184Rhinitis, Allergic
The Second Hospital of Nanjing Medical University
Not applicable
32
Nanjing
2024-06-01
Recruiting
Effectiveness of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure
NCT06493292Hemodialysis Access Failure
RenJi Hospital
Observational
180
Zhengzhou, Nanjing, Shanghai
2024-06-01
Active, closed
Prediction of Detoxification Effect of Fat Emulsion Based on Drug Diffusion Law
NCT06926439Poisoning, Toxicokinetics, Lipid Emulsion
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
85
Nanjing
2024-06-01
Recruiting
B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis
NCT06612411Irritable Bowel Syndrome with Diarrhea, Purine Metabolism Disorder
Jinling Hospital, China
Phase EARLY_PHASE1
180
Nanjing
2024-06-01
Recruiting
Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites
NCT06427577Rhinitis, Allergic
The First Affiliated Hospital with Nanjing Medical University
Not applicable
40
Nanjing
2024-06-01
Not yet open
Effect of Antibiotic Pretreatment on the Efficacy of WMT in the Treatment of Chronic Constipation
NCT06427863Chronic Constipation
Faming Zhang
Not applicable
96
Nanjing
2024-06
Not yet open
Effect of Antibiotic Pretreatment on the Efficacy of WMT in the Treatment of Irritable Bowel Syndrome
NCT06437041Irritable Bowel Syndrome
Faming Zhang
Not applicable
96
Nanjing
2024-06
Active, closed
The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM
NCT06427252Gastric Cancer, Metastatic
The First Affiliated Hospital with Nanjing Medical University
Phase 2
50
Nanjing
2024-05-31
Not yet open
Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation
NCT06426758Graves Disease, Graves' Disease in Remission, Epstein-Barr Virus
Xiao-Ming Mao
Observational
300
Nanjing
2024-05-30
Recruiting
Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
NCT06520774Aortic Arch Aneurysm, Penetrating Aortic Ulcer
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
103
Beijing, Changsha, Chengdu, Fuzhou, Hanzhou, Kunming, Nanjing, Shanghai
2024-05-30
Recruiting
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
NCT06375044Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
130
Beijing, Fuzhou, Guangzhou, Zhengzhou, Nanjing, Tianjin, Hanzhou
2024-05-24
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
NCT06133972Systemic Lupus Erythematosus
Novartis Pharmaceuticals
Phase 3
550
Guangzhou, Shantou, Nanjing, Suzhou, Nanchang, Pingxiang, Changchun, Linyi
2024-05-21
Recruiting
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NCT06118840Intracranial Aneurysm, CT Angiography, Deep Learning, Double Bind Interaction
Jinling Hospital, China
Not applicable
6,450
Hefei, Wuhu, Guiyang, Zhengzhou, Shiyan, Nanjing, Xuzhou, Changchun
2024-05-20
Active, closed
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT06158841Multiple Myeloma
AbbVie
Phase 3
421
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Suzhou, Nanchang
2024-05-19
Recruiting
Screening of Biomarkers and Related Mechanisms for RIX
NCT07170358Xerostomia Due to Radiotherapy (Disorder)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
50
Nanjing, Hangzhou
2024-05-17
Recruiting
Fluorouracil Treatment Via Colon for Colorectal Cancer
NCT06385418Colorectal Cancer
The Second Hospital of Nanjing Medical University
Phase 2
40
Nanjing
2024-05-16
Not yet open
A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)
NCT06340490Systemic Lupus Erythematosus
Guangdong Ruishun Biotech Co., Ltd
Phase 1
24
Beijing, Nanjing, Shanghai
2024-05-15
Recruiting
Probiotics Combined with Enteral Nutrition Reduces Postoperative Infectious Complications in PD
NCT06719596Infectious Complications
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
68
Nanjing
2024-05-10
Not yet open
Multiple Study of Electroaccpuncture in ARDS
NCT06278675Acute Respiratory Distress Syndrome, Sepsis
Nanjing University of Traditional Chinese Medicine
Not applicable
264
Nanjing
2024-05-10
Not yet open
Concomitant Tricuspid Repair in Patients With Left Heart Surgery
NCT05595187Tricuspid Regurgitation, Mitral Regurgitation, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
400
Nanjing
2024-05-01
Recruiting
Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices
NCT06670157Gastric Varices Bleeding
Yu Chang
Not applicable
6
Nanjing
2024-05-01
Not yet open
Washed Microbiota Transplantation for Rhinitis
NCT06350448Rhinitis
The Second Hospital of Nanjing Medical University
Not applicable
40
Nanjing
2024-05-01
Recruiting
Characteristics of Papez Loop Neural Network in T2DM ๏ผˆType 2 Diabetes Mellitus๏ผ‰
NCT06912321Type 2 Diabetes, Insulin Resistance, Cognitive Impairment
Nanjing First Hospital, Nanjing Medical University
Observational
400
Nanjing
2024-05-01
Recruiting
A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma
NCT06497738Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University
Observational
112
Changzhou, Nanjing, Nantong, Taizhou, Yancheng
2024-05-01
Recruiting
Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis
NCT06421818Ulcerative Colitis
The Second Hospital of Nanjing Medical University
Phase 2
144
Nanjing
2024-05
Recruiting
DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
NCT06539182Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Dizal Pharmaceuticals
Phase 2
155
Hefei, Beijing, Guangzhou, Zhengzhou, Wuhan, Nanjing, Changchun, Dalian
2024-04-29
Recruiting
Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder
NCT06376331Attention-deficit/Hyperactivity Disorder
The Second Hospital of Nanjing Medical University
Observational
50
Nanjing
2024-04-28
Not yet open
Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
NCT06340828Diabetic Gastroparesis, Diabetic Gastropathy, Diabetic Gastroenteropathy, Diabetic Gastroparesis Associated With Type 2 Diabetes Mellitus
The Second Hospital of Nanjing Medical University
Not applicable
40
Nanjing
2024-04-20
Recruiting
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
NCT06405217DTC - Differentiated Thyroid Cancer, Thyroid Stimulating; Hormone, C, Radiotherapy; Complications
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2024-04-20
Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
NCT06319820Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC
Phase 3
641
Beijing, Changsha, Cheng Du Shi, Chongqing, Fuzhou, Guangzhou, Nanjing, Shanghai
2024-04-18
Recruiting
Washed Microbiota Transplantation for Tourette's Syndrome
NCT03764748Tourette Syndrome
The Second Hospital of Nanjing Medical University
Phase 1
30
Nanjing
2024-04-17
By invitation
The Development of Tinnitus in Patients With SSNHL: Insights From fMRI and Metabolomics
NCT06355102Sudden Sensorineural Hearing Loss, Tinnitus
The First Affiliated Hospital with Nanjing Medical University
Observational
90
Nanjing
2024-04-15
Recruiting
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
NCT06251947Ovarian Cancer, Cervical Cancer
Shandong University
Phase 2
83
Changsha, Nanjing, Jinan, Qingdao, Taiyuan, Hangzhou
2024-04-15
Recruiting
Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
NCT06361316Pancreatic Cancer, Adjuvant Therapy
Kuirong Jiang
Not applicable
53
Nanjing
2024-04-08
By invitation
The Diagnostic Value of Shear Wave Elastography and Viscosity Imaging Techniques in Diabetic Peripheral Neuropathy
NCT06773793Diabetic Peripheral Neuropathy (DPN)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
300
Nanjing
2024-04-07
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
NCT06312137Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
780
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Suzhou
2024-04-03
Recruiting
Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
NCT06698692ESCC
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2024-04-02
Not yet open
Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment
NCT06234150Breast Neoplasms, Exercise Therapy, Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction
The First Affiliated Hospital with Nanjing Medical University
Not applicable
90
Nanjing
2024-04-01
Recruiting
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
NCT06341595Gastric Cancer, Gastric Cancer Metastatic to Regional Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2024-04-01
Recruiting
Neural Changes in Stroke Patients During Challenging Walking Tasks.
NCT06764290Stroke
Nanjing Medical University
Observational
60
Nanjing
2024-04-01
Recruiting
Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response
NCT06467864Pneumonia, Ventilator-Associated, Respiratory Tract Infections, Prognosis
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2024-04-01
Recruiting
NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer
NCT06494514Locally Advanced Pancreatic Cancer
Du Juan
Not applicable
40
Nanjing
2024-04-01
Recruiting
Washed Microbiota Transplantation for Diabetic Gastroparesis
NCT06340217Diabetic Gastroparesis
The Second Hospital of Nanjing Medical University
Not applicable
46
Nanjing
2024-04-01
Rows per page Showing 701–800 of 1193
Previous 6 7 8 9 10 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/nanjing?page=8

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,193 of those studies with a site in Nanjing.

How many clinical trials are recruiting in Nanjing?

713 of the 1,193 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 232 have not yet opened recruitment, 216 are active but closed to new participants, and 32 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.